Kiran Bhavaraju-Sanka, MD, and Beth Stein, MD, focus on the best and most effective methods of engaging patients who have myasthenia gravis throughout their journey.
Beth Stein, MD
Advertisement
Beth Stein, MD, is the Chief of Neurology at St. Joseph’s Health and a board-certified neurologist with subspecialty certification in neuromuscular medicine. With more than 20 years of experience, she provides expert care for complex neurological conditions such as Guillain-Barré Syndrome, Myasthenia Gravis, and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Articles by Beth Stein, MD
Ratna Kiran Bhavaraju-Sanka, MD, and Beth Stein, MD, explore how understanding MG subtypes and patient characteristics enhances targeted therapy and personalized treatment.
It's important to enhance MG treatment outcomes with strong provider-patient relationships and ongoing monitoring, explain Ratna Kiran Bhavaraju-Sanka, MD, and Beth Stein, MD.
New guidelines and advocacy enhance myasthenia gravis treatment access, promoting proactive management and improved insurance coverage for diverse patient populations.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure
2
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
3
Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?
4
Body Size, Metabolism Impact Psoriasis Severity and Biologic Response
5
